LeddarTech annonce un financement d’au plus 9,0 millions de dollars américains et des conversions de 1,5 million de dollars américains de billets convertibles au prix de 2,00 $ US par action, soit un prix supérieur au cours des actions
August 19, 2024 08:00 ET
|
LeddarTech inc.
QUÉBEC, Canada, 19 août 2024 (GLOBE NEWSWIRE) -- LeddarTech® Holdings Inc. (« LeddarTech » ou la « Société ») (NASDAQ : LDTC), une société de logiciels automobiles qui fournit des...
LM Funding America Announces Pricing of Registered Direct Offering for Aggregate Gross Proceeds of $2.6 Million
August 16, 2024 09:29 ET
|
LM Funding America, Inc.
TAMPA, Fla., Aug. 16, 2024 (GLOBE NEWSWIRE) -- LM Funding America, Inc. (NASDAQ: LMFA) (“LM Funding” or the “Company”), a cryptocurrency mining and technology-based specialty finance company, today...
ReShape Lifesciences® Reports Second Quarter Ended June 30, 2024 Financial Results and Provides Corporate Update
August 14, 2024 16:05 ET
|
ReShape Lifesciences Inc
Entered into Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement with Biorad Medisys Significant Reduction in Overall Operating Expenses of 45.4% in the First Half of 2024 Compared...
Draganfly Announces 30% Quarter Over Quarter Revenue Increase with Second Quarter Results for 2024
August 13, 2024 16:50 ET
|
Draganfly Inc
Vancouver, BC., Aug. 13, 2024 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and systems...
TenX Keane Acquisition Addresses Trading Halt, Continues Towards Closing of Business Combination, and Provides Market Update
August 09, 2024 07:30 ET
|
TenX Keane Acquisition
TenX Keane shareholders voted to approve the previously announced merger with Citius Oncology at an extraordinary general meeting held on August 2, 2024 Post-merger company expected to trade on...
Iterum Therapeutics Announces Expiration and Results of Rights Offering
August 06, 2024 17:30 ET
|
Iterum Therapeutics PLC
DUBLIN and CHICAGO, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company”), a clinical-stage pharmaceutical company focused on developing next generation oral and...
Spartan Capital Securities, LLC and B2i Digital Announce the Spartan Capital Investor Conference 2024
August 05, 2024 09:00 ET
|
Spartan Capital Securities, LLC
Over 30 Companies to Present and Engage with Hundreds of Investors at the Iconic Pierre Hotel in New York City A Landmark Event Celebrating Spartan Capital’s 17 Years of Excellence in the Capital...
TenX Keane Acquisition Shareholders Approve Previously Announced Merger to Form Citius Oncology, Inc., a Publicly Listed Subsidiary of Citius Pharmaceuticals
August 05, 2024 08:00 ET
|
TenX Keane Acquisition
TenX Keane shareholders voted to approve the previously announced merger with Citius Oncology at an extraordinary general meeting held on August 2, 2024 Post-merger company expected to trade on...
SELLAS Life Sciences Announces $21.0 Million Registered Direct Offering Priced at a Premium to Market
July 31, 2024 08:30 ET
|
SELLAS Life Sciences Group, Inc.
NEW YORK, July 31, 2024 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of...
Chemomab Therapeutics Announces Closing of $10 Million Private Placement
July 30, 2024 09:00 ET
|
Chemomab Therapeutics
Chemomab closed a $10 million PIPE financing that included new and existing top tier investors and extends the cash runway through the beginning of 2026